Search
for
Sort by
Research 781–810 of 1000+
- The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Ritlecitinib: First Approval
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- A review of the treatment of male pattern hair loss
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Autologous Platelet‐Rich Plasma Efficacy in the Field of Regenerative Medicine: Product and Quality Control
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Erectile dysfunction: Is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial
- Novedades terapéuticas en tricología
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Platelet-Rich Plasma à la Carte
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- Abstracts
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Janus kinase inhibitors for alopecia areata: A narrative review
- Platelet-rich plasma in interventional dermatology and trichology: How far have we come?
- Management of Toxicities of Targeted Therapies
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?